{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:49:32Z","timestamp":1753890572659,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Paroxysmal atrial fibrillation (AF) is closely related to pathophysiologic processes and clinical outcomes. However, it is uncertain whether cryoablation of pulmonary veins isolation is effective and safe for patients with symptomatic and drug refractory AF episodes of &amp;lt;24-h duration.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The patients were designed into Group A (253 patients with paroxysmal AF episodes of &amp;lt;24-h duration) and Group B (253 patients with paroxysmal AF lasting for 24 h or longer) on a 1:1 basis by identical propensity scores. Mortality, stroke\/transient ischemic attack (TIA), and complications relevant to the cryoablation procedure were compared, and recurrence of atrial tachyarrhythmia was analyzed for clinical independent predictors.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The rate of atrial tachyarrhythmia recurrence was 21.74% in Group A and 30.04% in Group B, respectively (<jats:italic>P<\/jats:italic> = 0.042). At 12-month follow-up from the procedure, lower incidences of stroke\/TIA endpoint of the patients were observed in Group A compared with Group B by Kaplan\u2013Meier analysis [HR 0.34 (0.13\u20130.87), <jats:italic>P<\/jats:italic> = 0.025]. No significant differences in mortality and complications relevant to the cryoablation procedure were observed between Group A and Group B. Moreover, adjusted multivariable Cox regression analysis showed that &amp;lt;24-h paroxysmal AF type (HR 0.644, 95% CI: 0.455\u20130.913, <jats:italic>P<\/jats:italic> = 0.014) and left atrium diameter (LAD) (&amp;gt;40 mm) (HR 1.696, 95% CI: 1.046\u20132.750, <jats:italic>P<\/jats:italic> = 0.032) were independently associated with the incidence of recurrence of atrial tachyarrhythmia in the study.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our findings indicated that &amp;lt;24-h paroxysmal AF type was obviously associated with an increased success rate of cryoablation and reduced incidence of stroke\/TIA during the follow-up period. Therefore, there is superior effectiveness and similar safety in patients with AF episodes of &amp;lt;24-h duration compared with patients with longer paroxysmal AF duration.<\/jats:p>","DOI":"10.3389\/fcvm.2021.724378","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T05:34:17Z","timestamp":1635226457000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness and Safety of Cryoablation in Patients With Atrial Fibrillation Episodes of &lt;24 h Duration: A Propensity-Matched Analysis"],"prefix":"10.3389","volume":"8","author":[{"given":"Chunying","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1136\/heartjnl-2018-314267","article-title":"Mechanisms of atrial fibrillation","volume":"105","author":"Wijesurendra","year":"2019","journal-title":"Heart"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","article-title":"Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial","volume":"61","author":"Packer","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1540-8167.1995.tb00758.x","article-title":"Paroxysmal atrial fibrillation: a need for classification","volume":"6","author":"L\u00e9vy","year":"1995","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/HCQ.0000000000000100","article-title":"2020 Update to the 2016 ACC\/AHA clinical performance and quality measures for adults with atrial fibrillation or atrial flutter: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"77","author":"Heidenreich","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa945","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e208748","DOI":"10.1001\/jamanetworkopen.2020.8748","article-title":"Association of atrial fibrillation episode duration with arrhythmia recurrence following ablation: a secondary analysis of a randomized clinical trial","volume":"3","author":"Andrade","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/europace\/eus189","article-title":"Verification of pulmonary vein isolation during single transseptal cryoballoon ablation: a comparison between the classical circular mapping catheter and the inner lumen mapping catheter","volume":"14","author":"Chierchia","year":"2012","journal-title":"Europace"},{"key":"B9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.hrthm.2014.12.026","article-title":"Single 3-minute freeze for second-generation cryoballoon ablation: one-year follow-up after pulmonary vein isolation","volume":"12","author":"Ciconte","year":"2015","journal-title":"Heart Rhythm"},{"key":"B10","doi-asserted-by":"publisher","first-page":"f377","DOI":"10.1093\/europace\/eux279","article-title":"Single freeze per vein strategy with the second-generation cryoballoon for atrial fibrillation: a propensity score-matched study between 180- and 240-s application time in a large cohort of patients","volume":"20","author":"De Regibus","year":"2018","journal-title":"Europace"},{"key":"B11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/jcm9020350","article-title":"Activated clotting time monitoring during atrial fibrillation catheter ablation: does the anticoagulant matter?","volume":"9","author":"Martin","year":"2020","journal-title":"J Clin Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/0735-1097(90)90326-K","article-title":"The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm","volume":"16","author":"Suttorp","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1161\/01.CIR.98.20.2202","article-title":"Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling","volume":"98","author":"Fareh","year":"1998","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/FJC.0000000000000281","article-title":"Autonomic remodeling: how atrial fibrillation begets atrial fibrillation in the first 24 hours","volume":"66","author":"Zhang","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1161\/CIRCULATIONAHA.119.042622","article-title":"Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial","volume":"140","author":"Andrade","year":"2019","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijcard.2017.11.011","article-title":"Second-generation cryoballoon ablation as a first-line treatment of symptomatic atrial fibrillation: two-year outcome and predictors of recurrence after a single procedure","volume":"259","author":"Akkaya","year":"2018","journal-title":"Int J Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1161\/CIRCULATIONAHA.115.016871","article-title":"Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, controlled, noninferiority FreezeAF study","volume":"132","author":"Luik","year":"2015","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e015343","DOI":"10.1161\/JAHA.119.015343","article-title":"Characterization, pathogenesis, and clinical implications of inflammation-related atrial myopathy as an important cause of atrial fibrillation","volume":"9","author":"Packer","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/eurheartj\/ehu028","article-title":"Early management of atrial fibrillation to prevent cardiovascular complications","volume":"35","author":"Nattel","year":"2014","journal-title":"Eur Heart J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10840-020-00804-z","article-title":"Is the time of atrial fibrillation recurrence after cryoballoon ablation of paroxysmal atrial fibrillation influenced by the pattern of PV reconnections?","volume":"60","author":"Wieczorek","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1111\/jce.14459","article-title":"Cryoballoon ablation for pulmonary vein isolation","volume":"31","author":"Andrade","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/europace\/eus336","article-title":"Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher","volume":"15","author":"Lin","year":"2013","journal-title":"Europace"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.cjca.2019.06.006","article-title":"Periprocedural anticoagulation for cardioversion of acute onset atrial fibrillation and flutter: evidence base for current guidelines","volume":"35","author":"Andrade","year":"2019","journal-title":"Can J Cardiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.724378\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T05:34:18Z","timestamp":1635226458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.724378\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":26,"alternative-id":["10.3389\/fcvm.2021.724378"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.724378","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"article-number":"724378"}}